Preface
Preface
Translational Lung Cancer Research
2014;
3
(2)
:64-65
.
(15 April 2014)
Review Article
10th Congress on Lung Cancer—updates on clinical trials: goal
Translational Lung Cancer Research
2014;
3
(2)
:66-69
.
(15 April 2014)
Concordance of IHC, FISH and RT-PCR for EML4-ALK rearrangements
Translational Lung Cancer Research
2014;
3
(2)
:70-74
.
(15 April 2014)
Hippo/YAP pathway for targeted therapy
Translational Lung Cancer Research
2014;
3
(2)
:75-83
.
(15 April 2014)
Targeted therapy in NSCLC driven by HER2 insertions
Translational Lung Cancer Research
2014;
3
(2)
:84-88
.
(15 April 2014)
Mini-Review Article
Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer
Translational Lung Cancer Research
2014;
3
(2)
:89-94
.
(15 April 2014)
Review Article
State of the art in surgery for early stage NSCLC—does the number of resected lymph nodes matter?
Translational Lung Cancer Research
2014;
3
(2)
:95-99
.
(15 April 2014)
Original Article
Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment
Translational Lung Cancer Research
2014;
3
(2)
:100-106
.
(15 April 2014)
Review Article
Predicting resistance by selection of signaling pathways
Translational Lung Cancer Research
2014;
3
(2)
:107-115
.
(15 April 2014)
How old is “too old” for translational research?
Translational Lung Cancer Research
2014;
3
(2)
:116-119
.
(15 April 2014)
Disclosure:
The focused issue “the 10th Congress of Spanish Lung Cancer Group I” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Rafael Rosell, Bartomeu Massuti and Niki Karachaliou served as the unpaid Guest Editors for the focused issue.
